| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/04/2008 | US20080213212 Using sialoadhesin specific immunoglobulin as diagnostic and/or therapeutic tool in treatment and prevention of allergic, respiratory, cell proliferative and skin disorders |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213171 Cancerous disease modifying antibodies |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 09/04/2008 | US20080213168 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 09/04/2008 | US20080213167 administering an anti-CD23 antibody and chlorambucil; B cell chronic lymphocytic leukemia |
| 09/04/2008 | US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas |
| 09/04/2008 | CA2686840A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679399A1 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2677075A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | CA2676049A1 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | CA2673607A1 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 09/04/2008 | CA2660592A1 Humanized fc.gamma.riib-specific antibodies and methods of use thereof |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964851A1 Treatment of micro-organism infection |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963558A1 Method for preparing a textile material and textile material thus prepared and produced |
| 09/03/2008 | EP1963522A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 09/03/2008 | EP1963513A2 Allergy inhibitor compositions and kits and methods of using the same |
| 09/03/2008 | EP1963484A1 Method of producing rough strains of bacteria and uses thereof |
| 09/03/2008 | EP1963482A1 Avirulent isolate of neospora caninum and its uses |
| 09/03/2008 | EP1963372A2 Anti-mn antibodies and methods of using same |
| 09/03/2008 | EP1963369A2 Il-21 antagonists |
| 09/03/2008 | EP1962961A1 Demibodies: dimerisation-activated therapeutic agents |
| 09/03/2008 | EP1962910A2 Novel prime-boost combinations of attenuated mycobacterium |
| 09/03/2008 | EP1962904A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 09/03/2008 | EP1962902A2 Methods and compositions relating to adhesins as adjuvants |
| 09/03/2008 | EP1962901A2 Compositions and methods relating to treatment of cancer and infectious diseases |
| 09/03/2008 | EP1962900A2 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 09/03/2008 | EP1962899A2 Pneumococcal polysaccharide conjugate vaccine |
| 09/03/2008 | EP1962898A1 Use of whole cell actinomycetales bacteria to treat stress-induced pulmonary haemorrhage |
| 09/03/2008 | EP1962897A1 Use of whole bacterial cells (actinomycetales) for maternal administration to modulate offspring immune response |
| 09/03/2008 | EP1962896A2 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
| 09/03/2008 | EP1962895A2 Therapeutic methods for inhibiting tumor growth with dll4 antagonists |
| 09/03/2008 | EP1962894A2 Method for assembling a polymer-biologic delivery composition |
| 09/03/2008 | EP1962893A1 Chimeric viruses presenting non-native surface proteins and uses thereof |
| 09/03/2008 | EP1962892A2 Inhibition of cell proliferation |
| 09/03/2008 | EP1962891A1 Dna vaccine for cancer therapy |
| 09/03/2008 | EP1962890A2 Immunogenic composition |
| 09/03/2008 | EP1962889A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 09/03/2008 | EP1765289B1 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 09/03/2008 | EP1693067A4 Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 09/03/2008 | EP1587789B1 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 09/03/2008 | EP1476468B1 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1463520B1 Immunisation against chlamydia trachomatis |
| 09/03/2008 | EP1411978B1 Botulinum toxin in the treatment or prevention of acne |
| 09/03/2008 | EP1411118B1 Cell proliferation inhibitors containing anti-glypican-3 antibody |
| 09/03/2008 | EP1351988B1 Group 2 allergen specific igg molecules and use thereof |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1294889B1 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 09/03/2008 | EP1200121B1 Fish vaccine |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | EP1137769B1 Methods for the generation of dna libraries |
| 09/03/2008 | EP0934339B1 Detoxification by intramuscular administration of F(ab') 2 fragments |
| 09/03/2008 | EP0923940B1 Peptide-based immunotherapeutic agent for allergic diseases |
| 09/03/2008 | EP0710116B1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101258165A Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 09/03/2008 | CN101257923A Anti-ccr7 receptor antibodies for the treatment of cancer |
| 09/03/2008 | CN101257922A Immune globulin main including Man7GlcNAc2, Man8GlcNAc sugar type |
| 09/03/2008 | CN101257921A Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| 09/03/2008 | CN101257920A Methods and compositions relating to a vaccine against prostate cancer |
| 09/03/2008 | CN101257919A Antigen-and-drug vehicle which enables the changeover from the selective production of lgA antibody to the production of both of lgA and lgG antibodies, and transnasal/transmucosal vaccine using the v |
| 09/03/2008 | CN101255442A LMP-1 recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255434A Vaccines |
| 09/03/2008 | CN101255433A Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 09/03/2008 | CN101255425A OX2 receptor homolog |
| 09/03/2008 | CN101255196A Immune globulin single variant antigen bonding land and specificity construction body thereof |
| 09/03/2008 | CN101255195A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection |
| 09/03/2008 | CN101254304A Medicaments for treating micro-organism infection and use thereof |
| 09/03/2008 | CN101254303A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 09/03/2008 | CN101254301A Preparation of HSP65 recombination protein and use thereof |
| 09/03/2008 | CN100415897C Microorganisms and cells for diagnosis and therapy of tumors |
| 09/03/2008 | CN100415895C Non-splicing variant of gp 350/220 |
| 09/03/2008 | CN100415891C Rabbit hemorrhagic disease vaccine and antigens |
| 09/03/2008 | CN100415876C Aids recombination gland virus vaccine |
| 09/03/2008 | CN100415871C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/03/2008 | CN100415771C Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use |
| 09/03/2008 | CN100415294C Medicine for treating and/or preventing hepatitis B |
| 09/02/2008 | US7421347 Identifying oligonucleotides for in vitro recombination |
| 09/02/2008 | US7420047 Nucleotide sequence encoding antigenic peptide; induces immune response which does not cause anaphylaxis when administered; safety |
| 09/02/2008 | US7420045 IAPs associated cell cycle proteins, compositions and methods of use |
| 09/02/2008 | US7420043 Reagents for detecting efavirenz |
| 09/02/2008 | US7420037 Heat shock protein-based vaccines and immunotherapies |
| 09/02/2008 | US7420034 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use in vaccines |
| 09/02/2008 | US7420028 Replikins and methods of identifying replikin-containing sequences |
| 09/02/2008 | US7419957 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419816 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |